MetaCap

Takeda Pharmaceutical (TAK) vs Teva Pharmaceutical Industries (TEVA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Teva Pharmaceutical Industries (TEVA) has outperformed Takeda Pharmaceutical (TAK) over the past year, gaining 62.0% versus a gain of 52.2%. Over five years, TEVA leads with a +362.1% price change compared with +60.9% for TAK. Takeda Pharmaceutical is the larger company by market cap ($69.55 billion vs $45.77 billion), about 1.5 times the size.

On valuation, Teva Pharmaceutical Industries trades at a lower forward P/E (12.5x vs 41.1x for Takeda Pharmaceutical). Takeda Pharmaceutical pays a dividend yielding 927.88%, while Teva Pharmaceutical Industries does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

TAK+52.24%TEVA+62.04%
+88%+41%-5%
Nov 21, 20251 yearNov 20, 2026
TAK+55.39%TEVA+341.78%
+422%+190%-42%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

TAK versus TEVA key metrics
MetricTAKTEVA
Share price$21.77$39.23
Market cap$69.55B$45.77B
1-day change+1.68%+1.79%
YTD return+39.64%+25.70%
1-year return+52.24%+62.04%
5-year return+60.90%+362.07%
P/E ratio (TTM)311.0091.23
Forward P/E41.0812.53
EPS (TTM)$0.07$0.43
Dividend yield927.88%0.00%
Annual dividend$202.00$0.00
Revenue (latest FY)—$17.26B
Revenue growth (YoY)—+4.32%
Net income (latest FY)—$1.41B
Gross margin—51.79%
Operating margin—12.50%
Net margin—8.17%
52-week high$22.07$44.57
52-week low$14.16$24.34
Distance from 52-week high-1.36%-11.98%
Analyst consensusstrong_buybuy
Avg. price target upside+12.68%+28.19%
Average volume2.73M6.31M
Shares outstanding3.19B1.17B
Employees47,02931,173
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Takeda Pharmaceutical trades at a higher earnings multiple (311.0x vs 91.2x trailing P/E).
  • Takeda Pharmaceutical offers a meaningfully higher dividend yield (927.88% vs 0.00%).

About Takeda Pharmaceutical

TAK stock →

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.

Health Care · Biotechnology: Pharmaceutical Preparations · 47,029 employees

About Teva Pharmaceutical Industries

TEVA stock →

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products.

Health Care · Biotechnology: Pharmaceutical Preparations · 31,173 employees

TAK vs TEVA FAQ

Which is bigger, Takeda Pharmaceutical or Teva Pharmaceutical Industries?

Takeda Pharmaceutical (TAK) is larger, with a market capitalization of $69.55B compared with $45.77B for Teva Pharmaceutical Industries (TEVA).

Which stock has performed better over the past year, TAK or TEVA?

TEVA returned +62.04% over the past 12 months, compared with +52.24% for TAK (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, TAK or TEVA?

TEVA has the lower trailing P/E at 91.2, versus 311.0 for TAK. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Takeda Pharmaceutical or Teva Pharmaceutical Industries?

Takeda Pharmaceutical pays a dividend yielding 927.88%, while Teva Pharmaceutical Industries does not currently pay a regular dividend.

Are Takeda Pharmaceutical and Teva Pharmaceutical Industries in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons